Mechanistic Characterization of NABi as a Selective Inhibitor of SOD1G93A Aggregation: Structural Basis and Therapeutic Implications for ALS.
- DOI
- 10.1021/acschemneuro.5c00977
- Published
- 2026 Sep 2
- Container
- ACS chemical neuroscience
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acschemneuro.5c00977,
title = {Mechanistic Characterization of NABi as a Selective Inhibitor of SOD1G93A Aggregation: Structural Basis and Therapeutic Implications for ALS.},
author = {Nam MK and Oh Y and Choi Y and Lee J and Jeong GH and Park S and Yoo SA and Kim M and Kang S and Rhim H},
year = {2026},
journal = {ACS chemical neuroscience},
doi = {10.1021/acschemneuro.5c00977},
url = {https://doi.org/10.1021/acschemneuro.5c00977}
}RIS
TY - JOUR TI - Mechanistic Characterization of NABi as a Selective Inhibitor of SOD1G93A Aggregation: Structural Basis and Therapeutic Implications for ALS. AU - Nam MK AU - Oh Y AU - Choi Y AU - Lee J AU - Jeong GH AU - Park S AU - Yoo SA AU - Kim M AU - Kang S AU - Rhim H PY - 2026 JO - ACS chemical neuroscience DO - 10.1021/acschemneuro.5c00977 UR - https://doi.org/10.1021/acschemneuro.5c00977 ER -
APA
MK, N., Y, O., Y, C., J, L., GH, J., S, P., SA, Y., M, K., S, K., & H, R. (2026). Mechanistic Characterization of NABi as a Selective Inhibitor of SOD1G93A Aggregation: Structural Basis and Therapeutic Implications for ALS.. ACS chemical neuroscience. https://doi.org/10.1021/acschemneuro.5c00977
Source records
- pubmed · retrieved 2026-09-26T16:16:47.462Z
- europe-pmc · retrieved 2026-09-26T16:16:47.470Z